Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Buy
57
ITCI Quote, Financials, Valuation and Earnings
Last price:
$131.61
Seasonality move
:
14.29%
Day range:
$131.51 - $131.67
52-week range:
$64.09 - $131.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.95x
P/B ratio:
12.19x
Volume:
1.8M
Avg. volume:
2.1M
1-year change:
92.53%
Market cap:
$14B
Revenue:
$680.5M
EPS (TTM):
-$0.73
Earnings Data
Next earnings date for ITCI
May 07
2025
Most recent earnings per share
-$0.16
Missed by $0.05
(Feb 21/2025)
Consensus Estimate
-$0.11
(Feb 21/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ITCI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2025 | Q1 | $205.5M | -- | -- | -$0.15 | -- |
| 02/21/2025 | Q4 | $193.3M | $199.2M | -$0.16 | -$0.11 | -$0.05 |
| 10/30/2024 | Q3 | $172.4M | $175.2M | -$0.25 | -$0.20 | -$0.05 |
| 08/07/2024 | Q2 | $157.9M | $161.3M | -$0.16 | -$0.18 | $0.02 |
| 05/07/2024 | Q1 | $141.4M | $144.8M | -$0.16 | -$0.32 | $0.16 |
| 02/22/2024 | Q4 | $135.7M | $131.5M | -$0.30 | -$0.46 | $0.16 |
| 11/02/2023 | Q3 | -- | -- | -$0.25 | -$0.58 | $0.33 |
| 08/03/2023 | Q2 | -- | -- | -$0.45 | -$0.59 | $0.14 |
| 05/04/2023 | Q1 | -- | -- | -$0.46 | -$0.62 | $0.16 |
| 03/01/2023 | Q4 | -- | -- | -$0.45 | -$0.59 | $0.14 |
| 11/03/2022 | Q3 | -- | -- | -$0.57 | -$0.84 | $0.27 |
| 08/09/2022 | Q2 | -- | -- | -$0.92 | -$0.76 | -$0.16 |
| 05/10/2022 | Q1 | -- | -- | -$0.78 | -$0.91 | $0.13 |
| 03/01/2022 | Q4 | -- | -- | -$1.05 | -$0.99 | -$0.06 |
| 11/09/2021 | Q3 | -- | -- | -$0.95 | -$0.92 | -$0.03 |
| 08/09/2021 | Q2 | -- | -- | -$0.85 | -$0.79 | -$0.06 |
| 05/10/2021 | Q1 | -- | -- | -$0.65 | -$0.80 | $0.15 |
| 02/25/2021 | Q4 | -- | -- | -$0.76 | -$0.85 | $0.09 |
| 11/09/2020 | Q3 | -- | -- | -$0.79 | -$1.00 | $0.21 |
| 08/10/2020 | Q2 | -- | -- | -$0.96 | -$0.92 | -$0.04 |
| 05/07/2020 | Q1 | -- | -- | -$0.73 | -$0.89 | $0.16 |
| 03/02/2020 | Q4 | -- | -- | -$0.74 | -$0.84 | $0.10 |
| 11/05/2019 | Q3 | -- | -- | -$0.63 | -$0.82 | $0.19 |
| 08/07/2019 | Q2 | -- | -- | -$0.68 | -$0.84 | $0.16 |
| 05/08/2019 | Q1 | -- | -- | -$0.63 | -$0.87 | $0.24 |
| 02/27/2019 | Q4 | -- | -- | -$0.75 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | -$0.76 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$0.68 | -- | -- |
| 05/03/2018 | Q1 | -- | -- | -$0.65 | -- | -- |
| 03/01/2018 | Q4 | -- | -- | -$0.56 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.53 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | -$0.62 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | -$0.64 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | -$0.70 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.71 | -- | -- |
| 04/28/2016 | Q1 | -- | -- | -$0.64 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -$0.67 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | -$0.91 | -- | -- |
| 08/05/2015 | Q2 | -- | -- | -$0.61 | -- | -- |
| 04/30/2015 | Q1 | -- | -- | -$0.72 | -- | -- |
Intra-Cellular Therapies Earnings Questions
-
How Much did Intra-Cellular Therapies Generate in Revenue Last Quarter?
Intra-Cellular Therapies reported $199.2M worth of top line sales in its most recent quarter.
-
Did Intra-Cellular Therapies Beat Earnings Last Quarter?
Intra-Cellular Therapies announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.11 per share.
-
Is Intra-Cellular Therapies Profitable?
Intra-Cellular Therapies reported $178.8M that represents $1.69 per share over the last quarter.
-
What is the Analyst Consensus for Intra-Cellular Therapies EPS Next Year?
Intra-Cellular Therapies's earnings are forecast to decrease from -$0.72 per share to $0.13 per share next year representing a decrease of -51.45%.
-
When is Intra-Cellular Therapies's Earnings Date?
Intra-Cellular Therapies's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
